26-A-18730-ACC OUTCOMES OF VENTRICULAR TACHYCARDIA ABLATION VERSUS CLASS III ANTIARRHYTHMICS AS FIRST-LINE THERAPY IN PATIENTS WITH SARCOIDOSIS AND VENTRICULAR TACHYCARDIA
JACC · 2026-04 · 87 (13) · A79-A80
DOI: 10.1016/j.jacc.2026.02.198 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Yong Hao Yeo und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yeo, Y. H., Ong, T. E., Vignarajah, A., Rattanawong, P., DeSimone, C., Masry, H. Z. E., Lee, J. Z., & Sorajja, D. (2026). 26-A-18730-ACC OUTCOMES OF VENTRICULAR TACHYCARDIA ABLATION VERSUS CLASS III ANTIARRHYTHMICS AS FIRST-LINE THERAPY IN PATIENTS WITH SARCOIDOSIS AND VENTRICULAR TACHYCARDIA. JACC, 87(13), A79-A80. https://doi.org/10.1016/j.jacc.2026.02.198
Vancouver
Yeo YH, Ong TE, Vignarajah A, Rattanawong P, DeSimone C, Masry HZE, et al. 26-A-18730-ACC OUTCOMES OF VENTRICULAR TACHYCARDIA ABLATION VERSUS CLASS III ANTIARRHYTHMICS AS FIRST-LINE THERAPY IN PATIENTS WITH SARCOIDOSIS AND VENTRICULAR TACHYCARDIA. JACC. 2026;87(13):A79-A80. doi:10.1016/j.jacc.2026.02.198
BibTeX
@article{Yeo2026,
author = {Yeo, Yong Hao and Ong, Tze Ern and Vignarajah, Aravinthan and Rattanawong, Pattara and DeSimone, Christopher and Masry, Hicham Z. El and Lee, Justin Zon-Ern and Sorajja, Dan},
title = {26-A-18730-ACC OUTCOMES OF VENTRICULAR TACHYCARDIA ABLATION VERSUS CLASS III ANTIARRHYTHMICS AS FIRST-LINE THERAPY IN PATIENTS WITH SARCOIDOSIS AND VENTRICULAR TACHYCARDIA},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A79--A80},
doi = {10.1016/j.jacc.2026.02.198}
}
EUVIMED